Minerva Neurosciences(NERV)- NASDAQ
  • Eric Muathe | Send Message 22 Aug
    Reply
      • Eric Muathe | Send Message 12 Aug
        Reply
          • wilkinson99 | Send Message 10 Aug

            Premarket Top % Losers: $SPWR -30%, $GEVO -30%, $NVCN -29%, $MYGN -28%, $WGBS -26%, $TDW -25%, $PRGO -12%, $OHRP $GBSN $JDST $NERV $DUST
            Reply
              • Eric Muathe | Send Message 25 Jul

                BREAKOUT IDEAS [ As Per $STUDY VIDEO; http://tinyurl.com/on8fdzp ]; $LITE $MITK $MXL $MYOK $NERV http://tinyurl.com/jbm6jhl
                Reply
                  • Bhavneesh Sharma | Send Message 15 Jul

                    Minerva Neurosciences Is Under-Valued Despite The Recent Run-Up In Its Stock Price. $NERV http://seekingalpha.com/a/2dhn5
                    Reply
                      • Colin Macleod | Send Message 20 Jun

                        T3 Live Daily Recap: The Gap & Nap http://tinyurl.com/znqxosc $SPY $SPX $AAPL $NFLX $FB $TWTR $NUGT $GLD $NERV $USO
                        Reply
                          • Decision Analytics | Send Message 2 Jun

                            Could This Be The Next Celator? $MEIP, $NERV http://seekingalpha.com/a/2daio
                            Reply
                              • Colin Macleod | Send Message 31 May

                                Greatstockpix Watch List Video for June 1 http://bit.ly/1r2ae47 $SPY $CLRB $W $OPGN $APHB $NEOT $NERV $VSLR $BOSC $SODA $ANF $SRPT
                                Reply
                                  • timothy russell | Send Message 31 May

                                    $NERV drop down to red, $BOSC $VSLR and $CLF some nice morning movers with volume
                                    Reply
                                      • wilkinson99 | Send Message 31 May

                                        Premarket Top % Gainers: $CCE 72%, $CPXX 71%, $CLF 26%, $CBAY 15%, $UGAZ 13%, $SODA $TTM $CTRV $NPD $CHAU $CBYL $ENBL $WR $ABIL $NVCR $NERV
                                        Reply
                                          Company Description
                                          Minerva Neurosciences, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The company's product portfolio includes MIN-101, MIN-117, MIN-202 and... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States